Modified docetaxel and cisplatin in combination with capecitabine (DCX) as first-tine treatment in HER2-negative advanced gastric cancer
Küçük Resim Yok
Tarih
2014
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
American Society of Clinical Oncology
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
[Abstract Not Available]
Açıklama
50th Annual Meeting of the American-Society-of-Clinical-Oncology -- MAY 30-JUN 03, 2014 -- Chicago, IL
WOS: 000358613200461
WOS: 000358613200461
Anahtar Kelimeler
Modified Docetaxel, Cisplatin, Capecitabine (DCX), HER2-Negative, Gastric Cancer
Kaynak
50th Annual Meeting of the American-Society-of-Clinical-Oncology
WoS Q Değeri
Q1
Scopus Q Değeri
Cilt
32
Sayı
15
Künye
Bilici, A., Selçukbiricik, F., Demir, N., Öven Ustaalioğlu, B. B., Dikillitaş, M. ve Yıldız, Ö. (2014). Modified docetaxel and cisplatin in combination with capecitabine (DCX) as first-tine treatment in HER2-negative advanced gastric cancer. 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Chicago, IL: American Society of Clinical Oncology.
